231 related articles for article (PubMed ID: 19793342)
1. The prevalence and significance of cannabis use in patients prescribed chronic opioid therapy: a review of the extant literature.
Reisfield GM; Wasan AD; Jamison RN
Pain Med; 2009 Nov; 10(8):1434-41. PubMed ID: 19793342
[TBL] [Abstract][Full Text] [Related]
2. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.
Fishbain DA; Cole B; Lewis J; Rosomoff HL; Rosomoff RS
Pain Med; 2008; 9(4):444-59. PubMed ID: 18489635
[TBL] [Abstract][Full Text] [Related]
3. Medical cannabis and chronic opioid therapy.
Reisfield GM
J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):356-61. PubMed ID: 21133743
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
Manchikanti L; Manchikanti KN; Pampati V; Cash KA
Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
[TBL] [Abstract][Full Text] [Related]
5. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
[TBL] [Abstract][Full Text] [Related]
6. Association between mental health disorders, problem drug use, and regular prescription opioid use.
Sullivan MD; Edlund MJ; Zhang L; Unützer J; Wells KB
Arch Intern Med; 2006 Oct; 166(19):2087-93. PubMed ID: 17060538
[TBL] [Abstract][Full Text] [Related]
7. Predictors of resolution of aberrant drug behavior in chronic pain patients treated in a structured opioid risk management program.
Meghani SH; Wiedemer NL; Becker WC; Gracely EJ; Gallagher RM
Pain Med; 2009; 10(5):858-65. PubMed ID: 19523029
[TBL] [Abstract][Full Text] [Related]
8. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.
Wasan AD; Butler SF; Budman SH; Benoit C; Fernandez K; Jamison RN
Clin J Pain; 2007 May; 23(4):307-15. PubMed ID: 17449991
[TBL] [Abstract][Full Text] [Related]
9. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C.
Whitehead AJ; Dobscha SK; Morasco BJ; Ruimy S; Bussell C; Hauser P
J Pain Symptom Manage; 2008 Jul; 36(1):39-45. PubMed ID: 18358690
[TBL] [Abstract][Full Text] [Related]
10. Opioid use by patients in an orthopedics spine clinic.
Mahowald ML; Singh JA; Majeski P
Arthritis Rheum; 2005 Jan; 52(1):312-21. PubMed ID: 15641058
[TBL] [Abstract][Full Text] [Related]
11. Long-term opioid therapy, aberrant behaviors, and substance misuse: comparison of patients treated by resident and attending physicians in a general medical clinic.
Colburn JL; Jasinski DR; Rastegar DA
J Opioid Manag; 2012; 8(3):153-60. PubMed ID: 22798175
[TBL] [Abstract][Full Text] [Related]
12. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.
Gilson AM; Ryan KM; Joranson DE; Dahl JL
J Pain Symptom Manage; 2004 Aug; 28(2):176-88. PubMed ID: 15276196
[TBL] [Abstract][Full Text] [Related]
13. A comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain management.
Moore TM; Jones T; Browder JH; Daffron S; Passik SD
Pain Med; 2009 Nov; 10(8):1426-33. PubMed ID: 20021601
[TBL] [Abstract][Full Text] [Related]
14. Do users of regularly prescribed opioids have higher rates of substance use problems than nonusers?
Edlund MJ; Sullivan M; Steffick D; Harris KM; Wells KB
Pain Med; 2007; 8(8):647-56. PubMed ID: 18028043
[TBL] [Abstract][Full Text] [Related]
15. What is being done to address the new drug epidemic?
Dekker AH
J Am Osteopath Assoc; 2007 Sep; 107(9 Suppl 5):ES21-6. PubMed ID: 17908827
[TBL] [Abstract][Full Text] [Related]
16. Addiction to opioids in chronic pain patients: a literature review.
Højsted J; Sjøgren P
Eur J Pain; 2007 Jul; 11(5):490-518. PubMed ID: 17070082
[TBL] [Abstract][Full Text] [Related]
17. Screening for potential prescription opioid misuse in a michigan medicaid population.
Braker LS; Reese AE; Card RO; Van Howe RS
Fam Med; 2009; 41(10):729-34. PubMed ID: 19882397
[TBL] [Abstract][Full Text] [Related]
18. Codeine and oxycodone use in patients with chronic rheumatic disease pain.
Ytterberg SR; Mahowald ML; Woods SR
Arthritis Rheum; 1998 Sep; 41(9):1603-12. PubMed ID: 9751092
[TBL] [Abstract][Full Text] [Related]
19. Addiction and chronic pain: diagnostic and treatment dilemmas.
Modesto-Lowe V; Brooks D; Freedman K; Hargus E
Conn Med; 2007 Mar; 71(3):139-44. PubMed ID: 17405395
[TBL] [Abstract][Full Text] [Related]
20. Chronic opioid therapy in nonmalignant pain.
Portenoy RK
J Pain Symptom Manage; 1990 Feb; 5(1 Suppl):S46-62. PubMed ID: 1969892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
